However in other studies, MCP-1 was described to be higher in mild COVID-19 than in severe cases, probably due to inhibition in IFN signalling [28], suggesting a protective role of MCP-1 against the onset of cytokine storms. The gene discussed is CCL2; the disease is COVID-19.